nodes	percent_of_prediction	percent_of_DWPC	metapath
Procarbazine—CYP1B1—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.0284	0.0926	CbGpPWpGaD
Procarbazine—CYP1B1—Sulindac Metabolic Pathway—CYP1A2—chronic obstructive pulmonary disease	0.0189	0.0615	CbGpPWpGaD
Procarbazine—XDH—Oxidative Stress—SOD3—chronic obstructive pulmonary disease	0.0153	0.05	CbGpPWpGaD
Procarbazine—XDH—Effects of Nitric Oxide—NOS2—chronic obstructive pulmonary disease	0.0142	0.0463	CbGpPWpGaD
Procarbazine—CYP1B1—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A2—chronic obstructive pulmonary disease	0.013	0.0422	CbGpPWpGaD
Procarbazine—CYP1B1—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A2—chronic obstructive pulmonary disease	0.0118	0.0384	CbGpPWpGaD
Procarbazine—XDH—Effects of Nitric Oxide—NOS3—chronic obstructive pulmonary disease	0.0114	0.0372	CbGpPWpGaD
Procarbazine—XDH—Oxidative Stress—GCLC—chronic obstructive pulmonary disease	0.00999	0.0326	CbGpPWpGaD
Procarbazine—CYP1B1—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—chronic obstructive pulmonary disease	0.00941	0.0307	CbGpPWpGaD
Procarbazine—CYP1B1—Estrogen Receptor Pathway—CYP1A2—chronic obstructive pulmonary disease	0.00878	0.0286	CbGpPWpGaD
Procarbazine—CYP1B1—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00856	0.0279	CbGpPWpGaD
Procarbazine—CYP1B1—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic obstructive pulmonary disease	0.00856	0.0279	CbGpPWpGaD
Procarbazine—Atenolol—ADRB2—chronic obstructive pulmonary disease	0.00724	0.492	CrCbGaD
Procarbazine—XDH—Oxidative Stress—HMOX1—chronic obstructive pulmonary disease	0.00691	0.0225	CbGpPWpGaD
Procarbazine—CYP1B1—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00677	0.0221	CbGpPWpGaD
Procarbazine—XDH—Selenium Micronutrient Network—SOD3—chronic obstructive pulmonary disease	0.00648	0.0211	CbGpPWpGaD
Procarbazine—CYP1B1—Estrogen Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.00638	0.0208	CbGpPWpGaD
Procarbazine—XDH—Oxidative Stress—CYP1A1—chronic obstructive pulmonary disease	0.0061	0.0199	CbGpPWpGaD
Procarbazine—CYP1B1—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00598	0.0195	CbGpPWpGaD
Procarbazine—Ibuprofen—CXCL8—chronic obstructive pulmonary disease	0.00594	0.403	CrCbGaD
Procarbazine—CYP1B1—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.00519	0.0169	CbGpPWpGaD
Procarbazine—CYP1B1—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00492	0.016	CbGpPWpGaD
Procarbazine—CYP1B1—Melatonin metabolism and effects—CYP1A2—chronic obstructive pulmonary disease	0.00462	0.0151	CbGpPWpGaD
Procarbazine—XDH—Selenium Micronutrient Network—MPO—chronic obstructive pulmonary disease	0.00435	0.0142	CbGpPWpGaD
Procarbazine—CYP1B1—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00435	0.0142	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—GCLC—chronic obstructive pulmonary disease	0.0038	0.0124	CbGpPWpGaD
Procarbazine—CYP1B1—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.00358	0.0117	CbGpPWpGaD
Procarbazine—CYP1B1—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.00336	0.011	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—CYP1A2—chronic obstructive pulmonary disease	0.0032	0.0104	CbGpPWpGaD
Procarbazine—CYP1B1—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.0032	0.0104	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor Pathway—CYP1A2—chronic obstructive pulmonary disease	0.0032	0.0104	CbGpPWpGaD
Procarbazine—CYP1B1—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00299	0.00975	CbGpPWpGaD
Procarbazine—CYP1B1—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.00264	0.00862	CbGpPWpGaD
Procarbazine—CYP1B1—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.00258	0.00843	CbGpPWpGaD
Procarbazine—CYP1B1—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.00255	0.00831	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	0.00232	0.00757	CbGpPWpGaD
Procarbazine—CYP1B1—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00232	0.00757	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.00232	0.00757	CbGpPWpGaD
Procarbazine—XDH—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	0.00229	0.00746	CbGpPWpGaD
Procarbazine—CYP1B1—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00217	0.00708	CbGpPWpGaD
Procarbazine—CYP1B1—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.00209	0.00683	CbGpPWpGaD
Procarbazine—CYP1B1—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.00188	0.00612	CbGpPWpGaD
Procarbazine—CYP1B1—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.00185	0.00604	CbGpPWpGaD
Procarbazine—XDH—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	0.00176	0.00573	CbGpPWpGaD
Procarbazine—XDH—Selenium Micronutrient Network—ALB—chronic obstructive pulmonary disease	0.00175	0.00572	CbGpPWpGaD
Procarbazine—Ibuprofen—ALB—chronic obstructive pulmonary disease	0.00154	0.105	CrCbGaD
Procarbazine—CYP1B1—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.00152	0.00496	CbGpPWpGaD
Procarbazine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00148	0.00218	CcSEcCtD
Procarbazine—Flushing—Salbutamol—chronic obstructive pulmonary disease	0.00148	0.00218	CcSEcCtD
Procarbazine—Infection—Tiotropium—chronic obstructive pulmonary disease	0.00148	0.00217	CcSEcCtD
Procarbazine—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.00147	0.00217	CcSEcCtD
Procarbazine—Shock—Tiotropium—chronic obstructive pulmonary disease	0.00146	0.00215	CcSEcCtD
Procarbazine—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.00145	0.00214	CcSEcCtD
Procarbazine—Tension—Arformoterol—chronic obstructive pulmonary disease	0.00144	0.00212	CcSEcCtD
Procarbazine—Tension—Formoterol—chronic obstructive pulmonary disease	0.00144	0.00212	CcSEcCtD
Procarbazine—Chills—Salbutamol—chronic obstructive pulmonary disease	0.00143	0.00211	CcSEcCtD
Procarbazine—XDH—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	0.00143	0.00465	CbGpPWpGaD
Procarbazine—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.00143	0.0021	CcSEcCtD
Procarbazine—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.00143	0.0021	CcSEcCtD
Procarbazine—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.00142	0.0021	CcSEcCtD
Procarbazine—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.00142	0.0021	CcSEcCtD
Procarbazine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.0014	0.00207	CcSEcCtD
Procarbazine—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.00138	0.00203	CcSEcCtD
Procarbazine—Tremor—Formoterol—chronic obstructive pulmonary disease	0.00138	0.00203	CcSEcCtD
Procarbazine—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.00137	0.00202	CcSEcCtD
Procarbazine—Tension—Salbutamol—chronic obstructive pulmonary disease	0.00136	0.002	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.00135	0.00199	CcSEcCtD
Procarbazine—Tremor—Montelukast—chronic obstructive pulmonary disease	0.00135	0.00199	CcSEcCtD
Procarbazine—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.00135	0.00198	CcSEcCtD
Procarbazine—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.00134	0.00198	CcSEcCtD
Procarbazine—CYP1B1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.00134	0.00437	CbGpPWpGaD
Procarbazine—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.00133	0.00196	CcSEcCtD
Procarbazine—CYP1B1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.00132	0.00432	CbGpPWpGaD
Procarbazine—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.0013	0.00191	CcSEcCtD
Procarbazine—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.00129	0.0019	CcSEcCtD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	0.00128	0.00419	CbGpPWpGaD
Procarbazine—Cough—Arformoterol—chronic obstructive pulmonary disease	0.00128	0.00189	CcSEcCtD
Procarbazine—Cough—Formoterol—chronic obstructive pulmonary disease	0.00128	0.00189	CcSEcCtD
Procarbazine—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00127	0.00187	CcSEcCtD
Procarbazine—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.00127	0.00187	CcSEcCtD
Procarbazine—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.00127	0.00187	CcSEcCtD
Procarbazine—Cough—Montelukast—chronic obstructive pulmonary disease	0.00125	0.00185	CcSEcCtD
Procarbazine—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00125	0.00184	CcSEcCtD
Procarbazine—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.00125	0.00184	CcSEcCtD
Procarbazine—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.00125	0.00184	CcSEcCtD
Procarbazine—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.00125	0.00184	CcSEcCtD
Procarbazine—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.00125	0.00184	CcSEcCtD
Procarbazine—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.00125	0.00184	CcSEcCtD
Procarbazine—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.00125	0.00184	CcSEcCtD
Procarbazine—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.00125	0.00184	CcSEcCtD
Procarbazine—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00124	0.00183	CcSEcCtD
Procarbazine—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00124	0.00183	CcSEcCtD
Procarbazine—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.00124	0.00183	CcSEcCtD
Procarbazine—Neuropathy—Prednisone—chronic obstructive pulmonary disease	0.00124	0.00183	CcSEcCtD
Procarbazine—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.00122	0.0018	CcSEcCtD
Procarbazine—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.00122	0.0018	CcSEcCtD
Procarbazine—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.00122	0.0018	CcSEcCtD
Procarbazine—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.00122	0.0018	CcSEcCtD
Procarbazine—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.00122	0.0018	CcSEcCtD
Procarbazine—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.00122	0.0018	CcSEcCtD
Procarbazine—XDH—Metabolism—APIP—chronic obstructive pulmonary disease	0.00121	0.00396	CbGpPWpGaD
Procarbazine—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00121	0.00179	CcSEcCtD
Procarbazine—Cough—Salbutamol—chronic obstructive pulmonary disease	0.00121	0.00178	CcSEcCtD
Procarbazine—Oedema—Formoterol—chronic obstructive pulmonary disease	0.0012	0.00177	CcSEcCtD
Procarbazine—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.0012	0.00177	CcSEcCtD
Procarbazine—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.0012	0.00176	CcSEcCtD
Procarbazine—Infection—Formoterol—chronic obstructive pulmonary disease	0.00119	0.00175	CcSEcCtD
Procarbazine—Infection—Arformoterol—chronic obstructive pulmonary disease	0.00119	0.00175	CcSEcCtD
Procarbazine—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.00118	0.00174	CcSEcCtD
Procarbazine—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.00118	0.00174	CcSEcCtD
Procarbazine—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00118	0.00174	CcSEcCtD
Procarbazine—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.00118	0.00173	CcSEcCtD
Procarbazine—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00117	0.00173	CcSEcCtD
Procarbazine—Oedema—Montelukast—chronic obstructive pulmonary disease	0.00117	0.00173	CcSEcCtD
Procarbazine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.00117	0.00172	CcSEcCtD
Procarbazine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.00117	0.00172	CcSEcCtD
Procarbazine—Infection—Montelukast—chronic obstructive pulmonary disease	0.00117	0.00172	CcSEcCtD
Procarbazine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00116	0.00171	CcSEcCtD
Procarbazine—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.00115	0.0017	CcSEcCtD
Procarbazine—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.00115	0.00169	CcSEcCtD
Procarbazine—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.00113	0.00167	CcSEcCtD
Procarbazine—Infection—Salbutamol—chronic obstructive pulmonary disease	0.00112	0.00166	CcSEcCtD
Procarbazine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00112	0.00165	CcSEcCtD
Procarbazine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00112	0.00165	CcSEcCtD
Procarbazine—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.00112	0.00165	CcSEcCtD
Procarbazine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00111	0.00164	CcSEcCtD
Procarbazine—Shock—Salbutamol—chronic obstructive pulmonary disease	0.00111	0.00164	CcSEcCtD
Procarbazine—CYP1B1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.00111	0.00363	CbGpPWpGaD
Procarbazine—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.00111	0.00164	CcSEcCtD
Procarbazine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.0011	0.00163	CcSEcCtD
Procarbazine—CYP1B1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.0011	0.00358	CbGpPWpGaD
Procarbazine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00109	0.00161	CcSEcCtD
Procarbazine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.00109	0.00161	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00109	0.00161	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00109	0.00161	CcSEcCtD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	0.00109	0.00355	CbGpPWpGaD
Procarbazine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.00108	0.0016	CcSEcCtD
Procarbazine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.00108	0.0016	CcSEcCtD
Procarbazine—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.00108	0.00159	CcSEcCtD
Procarbazine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00108	0.00159	CcSEcCtD
Procarbazine—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.00107	0.00158	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.00107	0.00158	CcSEcCtD
Procarbazine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.00107	0.00157	CcSEcCtD
Procarbazine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.00107	0.00157	CcSEcCtD
Procarbazine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.00106	0.00156	CcSEcCtD
Procarbazine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.00106	0.00156	CcSEcCtD
Procarbazine—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00105	0.00155	CcSEcCtD
Procarbazine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00105	0.00155	CcSEcCtD
Procarbazine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.00104	0.00154	CcSEcCtD
Procarbazine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00104	0.00153	CcSEcCtD
Procarbazine—XDH—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	0.00104	0.00338	CbGpPWpGaD
Procarbazine—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00103	0.00152	CcSEcCtD
Procarbazine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00103	0.00152	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00103	0.00152	CcSEcCtD
Procarbazine—Pain—Formoterol—chronic obstructive pulmonary disease	0.00102	0.00151	CcSEcCtD
Procarbazine—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00102	0.00151	CcSEcCtD
Procarbazine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.00102	0.00151	CcSEcCtD
Procarbazine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.00102	0.00151	CcSEcCtD
Procarbazine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.00102	0.00151	CcSEcCtD
Procarbazine—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00102	0.0015	CcSEcCtD
Procarbazine—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.00101	0.00149	CcSEcCtD
Procarbazine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00101	0.00148	CcSEcCtD
Procarbazine—Pain—Montelukast—chronic obstructive pulmonary disease	0.001	0.00148	CcSEcCtD
Procarbazine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.001	0.00148	CcSEcCtD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	0.000998	0.00326	CbGpPWpGaD
Procarbazine—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000997	0.00147	CcSEcCtD
Procarbazine—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000996	0.00147	CcSEcCtD
Procarbazine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000993	0.00146	CcSEcCtD
Procarbazine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000992	0.00146	CcSEcCtD
Procarbazine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000987	0.00146	CcSEcCtD
Procarbazine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000987	0.00146	CcSEcCtD
Procarbazine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000986	0.00145	CcSEcCtD
Procarbazine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000984	0.00145	CcSEcCtD
Procarbazine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000982	0.00145	CcSEcCtD
Procarbazine—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.00098	0.00144	CcSEcCtD
Procarbazine—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.00098	0.00144	CcSEcCtD
Procarbazine—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.000979	0.00144	CcSEcCtD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	0.000979	0.00319	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	0.000979	0.00319	CbGpPWpGaD
Procarbazine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000976	0.00144	CcSEcCtD
Procarbazine—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000968	0.00143	CcSEcCtD
Procarbazine—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000968	0.00143	CcSEcCtD
Procarbazine—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00096	0.00141	CcSEcCtD
Procarbazine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000952	0.0014	CcSEcCtD
Procarbazine—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000952	0.0014	CcSEcCtD
Procarbazine—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000947	0.0014	CcSEcCtD
Procarbazine—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000947	0.0014	CcSEcCtD
Procarbazine—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000947	0.0014	CcSEcCtD
Procarbazine—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000947	0.0014	CcSEcCtD
Procarbazine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000944	0.00139	CcSEcCtD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000941	0.00307	CbGpPWpGaD
Procarbazine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000936	0.00138	CcSEcCtD
Procarbazine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000935	0.00138	CcSEcCtD
Procarbazine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000935	0.00138	CcSEcCtD
Procarbazine—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000932	0.00137	CcSEcCtD
Procarbazine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000932	0.00137	CcSEcCtD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	0.000932	0.00304	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	0.000932	0.00304	CbGpPWpGaD
Procarbazine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00093	0.00137	CcSEcCtD
Procarbazine—CYP1B1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000928	0.00303	CbGpPWpGaD
Procarbazine—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000928	0.00137	CcSEcCtD
Procarbazine—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000928	0.00137	CcSEcCtD
Procarbazine—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000925	0.00136	CcSEcCtD
Procarbazine—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000918	0.00135	CcSEcCtD
Procarbazine—CYP1B1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000915	0.00298	CbGpPWpGaD
Procarbazine—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000913	0.00135	CcSEcCtD
Procarbazine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000899	0.00132	CcSEcCtD
Procarbazine—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000894	0.00132	CcSEcCtD
Procarbazine—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000894	0.00132	CcSEcCtD
Procarbazine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000883	0.0013	CcSEcCtD
Procarbazine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000883	0.0013	CcSEcCtD
Procarbazine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000882	0.0013	CcSEcCtD
Procarbazine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000865	0.00127	CcSEcCtD
Procarbazine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00086	0.00127	CcSEcCtD
Procarbazine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00086	0.00127	CcSEcCtD
Procarbazine—CYP1B1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000853	0.00278	CbGpPWpGaD
Procarbazine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000848	0.00125	CcSEcCtD
Procarbazine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000848	0.00125	CcSEcCtD
Procarbazine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000842	0.00124	CcSEcCtD
Procarbazine—CYP1B1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000841	0.00274	CbGpPWpGaD
Procarbazine—XDH—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	0.000836	0.00273	CbGpPWpGaD
Procarbazine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000834	0.00123	CcSEcCtD
Procarbazine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00083	0.00122	CcSEcCtD
Procarbazine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00082	0.00121	CcSEcCtD
Procarbazine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00082	0.00121	CcSEcCtD
Procarbazine—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000816	0.0012	CcSEcCtD
Procarbazine—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000813	0.0012	CcSEcCtD
Procarbazine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000812	0.0012	CcSEcCtD
Procarbazine—CYP1B1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000809	0.00264	CbGpPWpGaD
Procarbazine—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000808	0.00119	CcSEcCtD
Procarbazine—XDH—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000804	0.00262	CbGpPWpGaD
Procarbazine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000803	0.00118	CcSEcCtD
Procarbazine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000801	0.00118	CcSEcCtD
Procarbazine—CYP1B1—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000797	0.0026	CbGpPWpGaD
Procarbazine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000792	0.00117	CcSEcCtD
Procarbazine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000792	0.00117	CcSEcCtD
Procarbazine—XDH—Metabolism—GC—chronic obstructive pulmonary disease	0.000782	0.00255	CbGpPWpGaD
Procarbazine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000776	0.00114	CcSEcCtD
Procarbazine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000774	0.00114	CcSEcCtD
Procarbazine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000762	0.00112	CcSEcCtD
Procarbazine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000762	0.00112	CcSEcCtD
Procarbazine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000756	0.00111	CcSEcCtD
Procarbazine—Rash—Formoterol—chronic obstructive pulmonary disease	0.000756	0.00111	CcSEcCtD
Procarbazine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000755	0.00111	CcSEcCtD
Procarbazine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000755	0.00111	CcSEcCtD
Procarbazine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000751	0.00111	CcSEcCtD
Procarbazine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000751	0.00111	CcSEcCtD
Procarbazine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000748	0.0011	CcSEcCtD
Procarbazine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000746	0.0011	CcSEcCtD
Procarbazine—Rash—Montelukast—chronic obstructive pulmonary disease	0.00074	0.00109	CcSEcCtD
Procarbazine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000739	0.00109	CcSEcCtD
Procarbazine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000735	0.00108	CcSEcCtD
Procarbazine—XDH—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000727	0.00237	CbGpPWpGaD
Procarbazine—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000725	0.00107	CcSEcCtD
Procarbazine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000719	0.00106	CcSEcCtD
Procarbazine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000713	0.00105	CcSEcCtD
Procarbazine—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000713	0.00105	CcSEcCtD
Procarbazine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000713	0.00105	CcSEcCtD
Procarbazine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000712	0.00105	CcSEcCtD
Procarbazine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000712	0.00105	CcSEcCtD
Procarbazine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000709	0.00104	CcSEcCtD
Procarbazine—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000699	0.00103	CcSEcCtD
Procarbazine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000697	0.00103	CcSEcCtD
Procarbazine—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000689	0.00102	CcSEcCtD
Procarbazine—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000687	0.00101	CcSEcCtD
Procarbazine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000672	0.00099	CcSEcCtD
Procarbazine—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000667	0.000983	CcSEcCtD
Procarbazine—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000664	0.000978	CcSEcCtD
Procarbazine—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.00066	0.000973	CcSEcCtD
Procarbazine—CYP1B1—Metabolism—APIP—chronic obstructive pulmonary disease	0.00065	0.00212	CbGpPWpGaD
Procarbazine—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000649	0.000956	CcSEcCtD
Procarbazine—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000638	0.000941	CcSEcCtD
Procarbazine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000633	0.000933	CcSEcCtD
Procarbazine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000627	0.000925	CcSEcCtD
Procarbazine—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000616	0.000908	CcSEcCtD
Procarbazine—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000593	0.000874	CcSEcCtD
Procarbazine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000587	0.000865	CcSEcCtD
Procarbazine—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000587	0.000864	CcSEcCtD
Procarbazine—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000583	0.000859	CcSEcCtD
Procarbazine—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000555	0.000818	CcSEcCtD
Procarbazine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000535	0.000788	CcSEcCtD
Procarbazine—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000534	0.000787	CcSEcCtD
Procarbazine—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000518	0.000764	CcSEcCtD
Procarbazine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000516	0.00076	CcSEcCtD
Procarbazine—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000508	0.000748	CcSEcCtD
Procarbazine—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000501	0.000738	CcSEcCtD
Procarbazine—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000499	0.000735	CcSEcCtD
Procarbazine—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000492	0.000725	CcSEcCtD
Procarbazine—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000492	0.000725	CcSEcCtD
Procarbazine—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.00049	0.000722	CcSEcCtD
Procarbazine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000478	0.000705	CcSEcCtD
Procarbazine—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000472	0.000695	CcSEcCtD
Procarbazine—Infection—Prednisone—chronic obstructive pulmonary disease	0.000469	0.00069	CcSEcCtD
Procarbazine—Shock—Prednisone—chronic obstructive pulmonary disease	0.000464	0.000684	CcSEcCtD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000464	0.00151	CbGpPWpGaD
Procarbazine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.00046	0.000678	CcSEcCtD
Procarbazine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000456	0.000672	CcSEcCtD
Procarbazine—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.00045	0.000662	CcSEcCtD
Procarbazine—CYP1B1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000431	0.0014	CbGpPWpGaD
Procarbazine—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.00043	0.000633	CcSEcCtD
Procarbazine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000429	0.000632	CcSEcCtD
Procarbazine—XDH—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000427	0.00139	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000427	0.00139	CbGpPWpGaD
Procarbazine—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000427	0.000629	CcSEcCtD
Procarbazine—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000423	0.000624	CcSEcCtD
Procarbazine—XDH—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000423	0.00138	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—GC—chronic obstructive pulmonary disease	0.000419	0.00137	CbGpPWpGaD
Procarbazine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.00041	0.000604	CcSEcCtD
Procarbazine—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000409	0.000603	CcSEcCtD
Procarbazine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000409	0.000602	CcSEcCtD
Procarbazine—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000407	0.000599	CcSEcCtD
Procarbazine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000407	0.000599	CcSEcCtD
Procarbazine—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000403	0.000594	CcSEcCtD
Procarbazine—CYP1B1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.00039	0.00127	CbGpPWpGaD
Procarbazine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000389	0.000573	CcSEcCtD
Procarbazine—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000386	0.000568	CcSEcCtD
Procarbazine—XDH—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000386	0.00126	CbGpPWpGaD
Procarbazine—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000385	0.000568	CcSEcCtD
Procarbazine—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000375	0.000552	CcSEcCtD
Procarbazine—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000373	0.000549	CcSEcCtD
Procarbazine—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000373	0.000549	CcSEcCtD
Procarbazine—XDH—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000355	0.00116	CbGpPWpGaD
Procarbazine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000347	0.000512	CcSEcCtD
Procarbazine—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000338	0.000499	CcSEcCtD
Procarbazine—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000334	0.000492	CcSEcCtD
Procarbazine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000323	0.000475	CcSEcCtD
Procarbazine—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000312	0.00046	CcSEcCtD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.00031	0.00101	CbGpPWpGaD
Procarbazine—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.0003	0.000442	CcSEcCtD
Procarbazine—Rash—Prednisone—chronic obstructive pulmonary disease	0.000297	0.000438	CcSEcCtD
Procarbazine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000297	0.000438	CcSEcCtD
Procarbazine—XDH—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000296	0.000966	CbGpPWpGaD
Procarbazine—Headache—Prednisone—chronic obstructive pulmonary disease	0.000295	0.000435	CcSEcCtD
Procarbazine—XDH—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000292	0.000953	CbGpPWpGaD
Procarbazine—Nausea—Prednisone—chronic obstructive pulmonary disease	0.00028	0.000413	CcSEcCtD
Procarbazine—XDH—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000272	0.000888	CbGpPWpGaD
Procarbazine—XDH—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000258	0.000842	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000229	0.000747	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000226	0.000738	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	0.000211	0.000688	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000207	0.000673	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00019	0.00062	CbGpPWpGaD
Procarbazine—XDH—Metabolism—ALB—chronic obstructive pulmonary disease	0.000175	0.000572	CbGpPWpGaD
Procarbazine—XDH—Metabolism—NOS3—chronic obstructive pulmonary disease	0.000168	0.000547	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000159	0.000518	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000157	0.00051	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000146	0.000476	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000138	0.000451	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—ALB—chronic obstructive pulmonary disease	9.4e-05	0.000306	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—NOS3—chronic obstructive pulmonary disease	8.99e-05	0.000293	CbGpPWpGaD
